415 studies found for:    Open Studies | Exclude Unknown | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Recruiting The Evaluation Of PF-04950615 (RN316), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
22 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following Hospitalization for Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
23 Recruiting Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents
Condition: Single Ventricle Heart Disease After Fontan Surgery
Intervention: Drug: Udenafil
24 Not yet recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
25 Recruiting Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Condition: Atherosclerotic Coronary Vascular Disease
Intervention: Drug: Ranolazine
26 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
27 Recruiting Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation (PAF)
Interventions: Device: Blazer Open-Irrigated Ablation Catheter (Boston Scientific);   Device: FDA Approved Open-Irrigated Ablation Catheter
28 Recruiting MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Condition: Acute Stroke
Intervention: Drug: IV rt-PA
29 Recruiting A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
Conditions: Congestive Heart Failure;   Left Ventricular (LV) Systolic Dysfunction
Intervention: Device: CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
30 Recruiting Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia
Condition: Myocardial Ischemia
Interventions: Device: ADRCs processed by the Celution System;   Device: Placebo Comparator: Lactated Ringer's and Subject's Blood
31 Recruiting The Randomized Evaluation of VAD InterVEntion Before Inotropic Therapy
Condition: Congestive Heart Failure
Interventions: Device: HM II® (HeartMate II® LVAD);   Other: OMM (Optimal Medical Management)
32 Recruiting GORE® HELEX® Septal Occluder / GORE® Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical Study
Conditions: Stroke;   Transient Ischemic Attack
Intervention: Device: GORE® HELEX® Septal Occluder / GORE® Septal Occluder
33 Recruiting Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Device: Transcranial ultrasound as an adjunctive therapy to tPA;   Drug: Standard of care tPA therapy for acute ischemic stroke
34 Recruiting A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
Condition: Acute Coronary Syndrome
Interventions: Drug: Losmapimod 7.5 mg twice daily;   Drug: Placebo twice daily
35 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
36 Recruiting Right to Left Cardiac Shunt Detection
Conditions: Right to Left Shunt;   Patent Foramen Ovale;   Atrial Septal Defect
Intervention: Device: Flow Detection System
37 Not yet recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
38 Recruiting Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Condition: Prevention & Control
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
39 Recruiting Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
Conditions: Stroke;   Brain Ischemia;   Vasospasm, Intracranial;   Hemorrhage, Intracranial
Interventions: Drug: Dexmedetomidine;   Drug: Fentanyl;   Drug: Midazolam
40 Recruiting Study of Botulinum Toxin and Recovery of Hand Function After Stroke
Condition: Stroke With Hemiparesis
Intervention: Drug: Botulinum Toxin commonly known as BOTOX®

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years